Cian Healthcare Limited

BSE:542678 Stock Report

Market Cap: ₹108.5m

Cian Healthcare Past Earnings Performance

Past criteria checks 2/6

Cian Healthcare has been growing earnings at an average annual rate of 26.4%, while the Pharmaceuticals industry saw earnings growing at 13.5% annually. Revenues have been growing at an average rate of 1.6% per year. Cian Healthcare's return on equity is 0.4%, and it has net margins of 0.4%.

Key information

26.4%

Earnings growth rate

28.7%

EPS growth rate

Pharmaceuticals Industry Growth17.5%
Revenue growth rate1.6%
Return on equity0.4%
Net Margin0.4%
Last Earnings Update31 Mar 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Cian Healthcare makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

BSE:542678 Revenue, expenses and earnings (INR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 246193980
31 Dec 2362721000
30 Sep 2363411020
30 Jun 23661111020
31 Mar 23687201010
31 Dec 22689-71080
30 Sep 22690-341140
30 Jun 22735-451090
31 Mar 22781-551040
31 Dec 21800-30930
30 Sep 21820-6810
30 Jun 21779-2800
31 Mar 217391780
31 Dec 20704-22280
30 Sep 20668-281620
30 Jun 20621-331580
31 Mar 20573-38490
31 Dec 19586-37900
30 Sep 19601-42760
30 Jun 19617-18690
31 Mar 196347620
31 Mar 1859640480
31 Mar 1751823460
31 Mar 1647115460

Quality Earnings: 542678 has high quality earnings.

Growing Profit Margin: 542678's current net profit margins (0.4%) are lower than last year (3%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 542678 has become profitable over the past 5 years, growing earnings by 26.4% per year.

Accelerating Growth: 542678's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 542678 had negative earnings growth (-87.5%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (20.4%).

Return on Equity

High ROE: 542678's Return on Equity (0.4%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 12:20
End of Day Share Price 2024/12/23 00:00
Earnings2024/03/31
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Cian Healthcare Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution